In vivo, the serum kynurenine/tryptophan ratio has been directly associated with either IDO1 or TDO2 expression and is correlated with disease progression in multiple cancer types, including breast, lung, colon and liver carcinomas [62,63,64,65]. This evidence concerns the gene IDO1 and cancer.